Macrophage colony-stimulating factor promotes the survival of osteoclast precursors by up-regulating Bcl-X(L)

Exp Mol Med. 2002 Nov 30;34(5):340-6. doi: 10.1038/emm.2002.48.

Abstract

Macrophage colony-stimulating factor (M-CSF) is known as one of the factors essential for osteoclast development. In the present study, we examined effects of M-CSF on the apoptotic pathway of osteoclast precursors and their underlying molecular mechanisms. Osteoclast precursors underwent apoptosis in the absence of M-CSF, even in the presence of receptor activator of NF-kappakB ligand (RANKL). Active caspase-3 and -9 were detected in the osteoclast precursors and treatments of precursors with their specific inhibitors (Z-DEVD-FMK and Z-LEHD-FMK) decreased the apoptosis. M-CSF decreased apoptosis in a dose-dependent manner with decreasing in active caspases-3 and -9 levels and up-regulating Bcl-X(L). Those effects of M-CSF on inhibiting apoptosis of osteoclasts precursor by regulating anti-apoptotic signals was more effective when combined with RANKL. These results demonstrate that M-CSF acts as a survival factor for the osteoclast precursors. Furthermore, it is believed that the apoptosis of osteoclast precursors may be involved in the activation of caspase-9 and that M-CSF may promote their survival through Bcl-X(L)-induced inhibition of caspase-9 activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Apoptosis / physiology
  • Carrier Proteins / pharmacology
  • Caspase 9
  • Caspase Inhibitors
  • Caspases / drug effects
  • Caspases / metabolism
  • Cell Survival / drug effects
  • Cells, Cultured
  • Cysteine Proteinase Inhibitors / pharmacology
  • Enzyme Activation / drug effects
  • Female
  • Macrophage Colony-Stimulating Factor / pharmacology*
  • Membrane Glycoproteins / pharmacology
  • Mice
  • Mice, Inbred ICR
  • Oligopeptides / pharmacology
  • Osteoclasts / cytology*
  • Osteoclasts / drug effects
  • Proto-Oncogene Proteins c-bcl-2 / drug effects
  • Proto-Oncogene Proteins c-bcl-2 / metabolism*
  • RANK Ligand
  • Receptor Activator of Nuclear Factor-kappa B
  • Stem Cells / cytology
  • Stem Cells / drug effects*
  • Up-Regulation
  • bcl-X Protein

Substances

  • Bcl2l1 protein, mouse
  • Carrier Proteins
  • Caspase Inhibitors
  • Cysteine Proteinase Inhibitors
  • Membrane Glycoproteins
  • Oligopeptides
  • Proto-Oncogene Proteins c-bcl-2
  • RANK Ligand
  • Receptor Activator of Nuclear Factor-kappa B
  • Tnfrsf11a protein, mouse
  • Tnfsf11 protein, mouse
  • bcl-X Protein
  • benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone
  • benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone
  • Macrophage Colony-Stimulating Factor
  • Casp9 protein, mouse
  • Caspase 9
  • Caspases